Avantor, Inc.
For the period ended Dec 31, 2025. Filed Feb 11, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 11, 2026
AVTR$15.91+2.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Glossaryii
Glossary
| Description | |
| the Company, we, us, our | Avantor, Inc. and its subsidiaries |
|---|---|
| 2019 Plan | the Avantor, Inc. 2019 Equity Incentive Plan, a stock-based compensation plan |
| Adjusted EBITDA | our earnings or loss before interest, taxes, depreciation, amortization and certain other adjustments |
| Adjusted Operating Income | our earnings or loss before interest, taxes, amortization and certain other adjustments |
| Advanced Lab Services | Services and products designed to optimize and manage end-to-end laboratory operations for customers across industries such as biopharma, education, industrial, and technology sectors |
| AI | artificial intelligence |
| AMEA | Asia, Middle-East and Africa |
| AOCI | accumulated other comprehensive income or loss |
| Applied Solutions | Proprietary formulated solutions for semiconductor manufacturing, proprietary chemicals for healthcare, biopharma, and diagnostic applications as well as chemicals and PPE for industrial applications |
| ASC | Accounting Standards Codification |
| ASU | Accounting Standards Update |
| Bioprocessing | Process ingredients and excipients, single use systems and integrated solutions, and controlled environment consumables used to support the production of biologic drugs and therapies |
| BIS | the Bureau of Industry and Security |
| CERCLA | the Comprehensive Environmental Response Compensation and Liability Act |
| cGMP | Current Good Manufacturing Practice |
| CODM | chief operating decision maker |
| COVID-19 | Coronavirus disease of 2019 |
| DDTC | Directorate of Defense Trade Controls |
| DEA | Drug Enforcement Administration |
| DHHS | Department of Health and Human Services |
| EMA | European Medicines Agency |
| EPA | the U.S. Environmental Protection Agency |
| ERP | enterprise resource planning |
| EU | European Union |
| EURIBOR | the basic rate of interest used in lending between banks on the European Union interbank market |
| FASB | the Financial Accounting Standards Board of the United States |
ii
| Description | |
| FCPA | the United States Foreign Corrupt Practices Act |
|---|---|
| FDA | United States Food and Drug Administration |
| FDII | Foreign-Derived Intangible Income |
| GAAP | United States generally accepted accounting principles |
| GDPR | the General Data Protection Regulation |
| GILTI | Global Intangible Low-Taxed Income |
| ICH Q7 | the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use - Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients |
| IPO | initial public offering |
| ISO | International Organization for Standardization or international equivalents |
| ITAR | the International Traffic In Arms Regulations |
| Laboratory Specialty Products | Proprietary chemicals and products for multiple industries, including biopharma, healthcare, industrial, mining, and education, among others |
| Long-Term | period other than Short-Term |
| Masterflex | Masterflex LLC, a company we acquired in November 2021 |
| NAV | Net Asset Value |
| NIH | National Institutes of Health |
| NuSil | NuSil Acquisition Corp, NuSil Investments LLC and subsidiaries, a business organization with which we merged in 2016 |
| NYSE | the New York Stock Exchange |
| OCI | other comprehensive income or loss |
| OEM | original engineering manufacturers |
| OFAC | the U.S. Department of the Treasury’s Office of Foreign Assets Control |
| OSHA | the U.S. Occupational Safety & Health Administration |
| Ritter | Ritter GmbH and affiliates, a company we acquired in June 2021 |
| RSU | restricted stock units represent equity awards that may be subject to service, performance, or market conditions, or a combination of these criteria |
| SEC | the United States Securities and Exchange Commission |
| SG&A expenses | selling, general and administrative expenses |
| Short-Term | period less than a year from the reporting date |
| Silicones | Ultra-high purity medical and aerospace grade silicone formulations |
| SKU | stock keeping unit |
| SOFR | secured overnight financing rate |
| specialty procurement | product sales related to customer procurement services |
| Total Science Solutions | Mission-critical consumables, chemicals, and equipment and instrumentation used by scientists in their labs |
| VWR | VWR Corporation and its subsidiaries, a company we acquired in November 2017 |
iii
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.